Compounds > 9,10-dimethyl-1,2-benzanthracene
Page last updated: 2024-08-17

9,10-dimethyl-1,2-benzanthracene and Ductal Carcinoma

9,10-dimethyl-1,2-benzanthracene has been researched along with Ductal Carcinoma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gear, R; Heffelfinger, SC; LaDow, K; Lu, F; Schneider, J; Warshawsky, D; Yan, M1

Other Studies

1 other study(ies) available for 9,10-dimethyl-1,2-benzanthracene and Ductal Carcinoma

ArticleYear
Expression of angiogenic factors is upregulated in DMBA-induced rat mammary pathologies.
    Pathobiology : journal of immunopathology, molecular and cellular biology, 2004, Volume: 71, Issue:5

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Angiogenic Proteins; Angiopoietin-1; Animals; Carcinogens; Carcinoma in Situ; Carcinoma, Ductal; Female; Fibroblast Growth Factor 2; Gene Expression Profiling; Gene Expression Regulation; Hyperplasia; Insulin Receptor Substrate Proteins; Insulin-Like Growth Factor I; Insulin-Like Growth Factor II; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Osteonectin; Phosphoproteins; Plasminogen Activator Inhibitor 1; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; Thrombospondin 1; Urokinase-Type Plasminogen Activator; Vascular Endothelial Growth Factor A

2004